24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
EpiPen
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:28
Intel to spin off networking group, stepping back from battle with Nvidia
21:04
Cyber unicorn Axonius acquires Cynerio in $180M deal to expand into healthcare security
19:05
Intel stock plunges as Tan warns foundry dreams could be scrapped
11:20
Intel’s new boss has no time for field of dreams
More stories
Buzz
Most popular
Daily
Weekly
1
Intel’s new boss has no time for field of dreams
2
Is Palo Alto Networks eyeing a SentinelOne takeover?
3
Intel stock plunges as Tan warns foundry dreams could be scrapped
4
Intel job cuts swell to 25,000 as CEO Tan plots costly turnaround
5
Cyber unicorn Axonius acquires Cynerio in $180M deal to expand into healthcare security
More news
EpiPen
4 stories about EpiPen
Teva Jumps on NYSE on a Bit of Good News
21.08.19
|
Hezi Sternlicht
An opioid-abuse lawsuit settlement reached by drugmakers Endo and Allergan Tuesday could bode well for Teva’s legal future, as does the release of an FDA-approved generic version of EpiPen JR
Teva, Mylan Drop on Announcement of Epinephrine Injector Rival
09.12.18
|
Lilach Baumer
Novartis’ U.S. division Sandoz announced a planned release for early 2019. The company will sell its drug, which lacks the EpiPen’s auto-injector, for $250 a pair out of pocket, compared to Mylan and Teva’s $300
Teva’s Generic EpiPen Now Available in the U.S. in Limited Numbers
28.11.18
|
Lilach Baumer
In August, the Israel-headquartered drugmaker won approval to market the first generic EpiPen auto-injectors in the U.S.
Teva’s EpiPen Won’t Hit U.S. Market in Time for School Year, Report Says
26.08.18
|
Dror Reich
The Israeli drugmaker received approval for a first generic version of Mylan’s auto-injector earlier this month